ChenGuang Biotech Group Co., Ltd. (300138.SZ)
CNY 8.97
(-0.44%)
CNY 8.97
(-0.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 8.53 Billion CNY | 23.34% |
| 2022 | 6.92 Billion CNY | 16.26% |
| 2021 | 5.95 Billion CNY | 27.94% |
| 2020 | 4.65 Billion CNY | 3.27% |
| 2019 | 4.5 Billion CNY | 34.25% |
| 2018 | 3.35 Billion CNY | 16.86% |
| 2017 | 2.87 Billion CNY | 15.26% |
| 2016 | 2.49 Billion CNY | 25.17% |
| 2015 | 1.99 Billion CNY | 32.03% |
| 2014 | 1.5 Billion CNY | -7.57% |
| 2013 | 1.63 Billion CNY | 12.87% |
| 2012 | 1.44 Billion CNY | 29.55% |
| 2011 | 1.11 Billion CNY | -2.88% |
| 2010 | 1.14 Billion CNY | 185.21% |
| 2009 | 402.84 Million CNY | 4.57% |
| 2008 | 385.24 Million CNY | 105.8% |
| 2007 | 187.19 Million CNY | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 9.08 Billion CNY | 6.34% |
| 2024 Q2 | 8.42 Billion CNY | -7.21% |
| 2024 Q3 | 7.74 Billion CNY | -8.02% |
| 2023 Q2 | 7.23 Billion CNY | -5.2% |
| 2023 Q1 | 7.63 Billion CNY | 10.31% |
| 2023 Q3 | 7.42 Billion CNY | 2.62% |
| 2023 Q4 | 8.53 Billion CNY | 14.94% |
| 2023 FY | 8.53 Billion CNY | 23.34% |
| 2022 FY | 6.92 Billion CNY | 16.26% |
| 2022 Q2 | 6.17 Billion CNY | 0.03% |
| 2022 Q3 | 6.5 Billion CNY | 5.28% |
| 2022 Q4 | 6.92 Billion CNY | 6.51% |
| 2022 Q1 | 6.17 Billion CNY | 3.66% |
| 2021 Q3 | 4.14 Billion CNY | -7.87% |
| 2021 FY | 5.95 Billion CNY | 27.94% |
| 2021 Q2 | 4.49 Billion CNY | -4.21% |
| 2021 Q1 | 4.69 Billion CNY | 0.83% |
| 2021 Q4 | 5.95 Billion CNY | 43.77% |
| 2020 Q2 | 4.68 Billion CNY | 5.77% |
| 2020 Q3 | 4.07 Billion CNY | -12.87% |
| 2020 FY | 4.65 Billion CNY | 3.27% |
| 2020 Q4 | 4.65 Billion CNY | 14.09% |
| 2020 Q1 | 4.42 Billion CNY | -1.78% |
| 2019 Q2 | 3.31 Billion CNY | -1.33% |
| 2019 FY | 4.5 Billion CNY | 34.25% |
| 2019 Q3 | 3.45 Billion CNY | 4.17% |
| 2019 Q4 | 4.5 Billion CNY | 30.33% |
| 2019 Q1 | 3.36 Billion CNY | 0.23% |
| 2018 Q3 | 2.97 Billion CNY | -0.2% |
| 2018 Q1 | 2.89 Billion CNY | 0.94% |
| 2018 FY | 3.35 Billion CNY | 16.86% |
| 2018 Q4 | 3.35 Billion CNY | 12.67% |
| 2018 Q2 | 2.98 Billion CNY | 2.97% |
| 2017 Q3 | 2.13 Billion CNY | -11.96% |
| 2017 Q4 | 2.87 Billion CNY | 34.62% |
| 2017 FY | 2.87 Billion CNY | 15.26% |
| 2017 Q1 | 2.42 Billion CNY | -2.9% |
| 2017 Q2 | 2.42 Billion CNY | 0.16% |
| 2016 Q4 | 2.49 Billion CNY | 24.51% |
| 2016 Q3 | 2 Billion CNY | 3.8% |
| 2016 Q2 | 1.92 Billion CNY | -2.37% |
| 2016 FY | 2.49 Billion CNY | 25.17% |
| 2016 Q1 | 1.97 Billion CNY | -0.8% |
| 2015 Q1 | 1.5 Billion CNY | -0.42% |
| 2015 Q3 | 1.41 Billion CNY | 1.27% |
| 2015 FY | 1.99 Billion CNY | 32.03% |
| 2015 Q4 | 1.99 Billion CNY | 40.49% |
| 2015 Q2 | 1.39 Billion CNY | -6.81% |
| 2014 Q2 | 1.46 Billion CNY | -9.91% |
| 2014 Q4 | 1.5 Billion CNY | 13.15% |
| 2014 Q3 | 1.33 Billion CNY | -9.18% |
| 2014 Q1 | 1.62 Billion CNY | -0.15% |
| 2014 FY | 1.5 Billion CNY | -7.57% |
| 2013 Q2 | 1.45 Billion CNY | -5.3% |
| 2013 FY | 1.63 Billion CNY | 12.87% |
| 2013 Q4 | 1.63 Billion CNY | 12.04% |
| 2013 Q3 | 1.45 Billion CNY | 0.07% |
| 2013 Q1 | 1.53 Billion CNY | 6.31% |
| 2012 Q3 | 1.27 Billion CNY | 3.79% |
| 2012 Q4 | 1.44 Billion CNY | 13.36% |
| 2012 Q1 | 1.19 Billion CNY | 6.78% |
| 2012 FY | 1.44 Billion CNY | 29.55% |
| 2012 Q2 | 1.22 Billion CNY | 3.12% |
| 2011 Q1 | 1.15 Billion CNY | 0.36% |
| 2011 Q2 | 1.08 Billion CNY | -5.81% |
| 2011 Q4 | 1.11 Billion CNY | 2.34% |
| 2011 FY | 1.11 Billion CNY | -2.88% |
| 2011 Q3 | 1.09 Billion CNY | 0.39% |
| 2010 Q3 | 475.42 Million CNY | 14.6% |
| 2010 Q4 | 1.14 Billion CNY | 141.67% |
| 2010 FY | 1.14 Billion CNY | 185.21% |
| 2010 Q2 | 414.84 Million CNY | 0.0% |
| 2009 Q4 | 402.84 Million CNY | 0.0% |
| 2009 FY | 402.84 Million CNY | 4.57% |
| 2008 FY | 385.24 Million CNY | 105.8% |
| 2007 FY | 187.19 Million CNY | 0.0% |